Skip to main content

Tricuspid Valve Insufficiency clinical trials at UCSF

2 research studies open to eligible people

Tricuspid valve insufficiency is when blood leaks backwards through the valve in the heart. At UCSF, there are clinical trials testing new valve replacement and repair systems. One trial is evaluating the Edwards EVOQUE system. Another trial is testing the effectiveness of the Edwards PASCAL Transcatheter Valve Repair System. Both trials are for patients with severe symptoms.

Showing trials for
  • Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

    open to eligible people ages 18 years and up

    To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

    San Francisco, California and other locations

  • TRISCEND II Pivotal Trial

    open to eligible people ages 18 years and up

    Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system

    San Francisco, California and other locations

Our lead scientists for Tricuspid Valve Insufficiency research studies include .

Last updated: